Autres langues Enveric Biosciences, Inc.

Actions

ENVB

US29405E2081

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 10/05/2024			Varia. 5j.	Varia. 1 janv.
0,89 ^USD	-3,26 %		-9,18 %	-31,54 %

08/05	Enveric Biosciences, Inc. annonce la signature d'un accord non contraignant avec une société non divulguée pour l'obtention d'une licence sur des méthodes brevetées de traitement du cancer du sein et d'autres cancers à l'aide de cannabinoïdes.	CI
26/03	Enveric Biosciences, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Enveric Biosciences Announces Signing of Non-Binding Term Sheet with Undisclosed Licensee for Exclusive License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids	08/05
Enveric Biosciences, Inc. Announces Signing of Non-Binding Term Sheet with Undisclosed License to Patented Methods of Treating Breast and Other Cancers Using Cannabinoids	08/05
Unlocking New Horizons: Enveric Biosciences’ Strategic Moves in Biotechnology [Microdose]	30/04
Enveric Biosciences : Shareholder Meeting - Form 8-K	28/03
Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2023	26/03
Enveric Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26/03
Sector Update: Health Care Stocks Rise Late Afternoon	19/03
Sector Update: Health Care Stocks Higher in Tuesday Afternoon Trading	19/03
Enveric Biosciences Signs Licensing Term Sheets for Joint Disease Treatment Compounds; Shares Rise	19/03
Wall Street Set to Open Lower Ahead of Two-Day Fed Meeting; Housing Starts Surge Higher Than Expected	19/03
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease	19/03
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of New Chemical Entities for Pharmaceutical and Non-Pharmaceutical Applications in Joint Disease	19/03
Enveric Biosciences Announces New Patent Issuances Protecting Multiple Assets Covered by Non-Binding Term Sheets	12/03
Enveric Biosciences Issues 228,690 Shares in Direct Offering	11/03
Top Midday Gainers	29/02
Wall Street Set to Open Higher Thursday as Inflation Data Meets Forecasts	29/02
Investors Await Slate of Economic Data as US Futures Move Lower in Thursday's Premarket Session	29/02
Enveric Biosciences Signs Non-Binding Term Sheets to Pursue the Exclusive Out-Licensing of Three Classes of Compounds	29/02
Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB	28/02
Enveric Biosciences Agrees to Sell Cancer-Targeting Cannabinoid-Related Intellectual Property	26/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Enveric Biosciences, Inc.

Actions

ENVB

US29405E2081

Autres langues

Filtres